{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:28:37Z","timestamp":1783988917911,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]},{"name":"SKLID Development Grants from the National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, China CDC","award":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"],"award-info":[{"award-number":["2021SKLID504, 2019SKLID401, 2019SKLID603, and 2021SKLID503"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01688-9","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:10:05Z","timestamp":1738941005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u03b2-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer\u2019s and Parkinson\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Bing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rundong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhan","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"1688_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136\u201344. https:\/\/doi.org\/10.1126\/science.6801762.","journal-title":"Science"},{"key":"1688_CR2","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1126\/science.6815801","volume":"218","author":"DC Bolton","year":"1982","unstructured":"Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science. 1982;218:1309\u201311. https:\/\/doi.org\/10.1126\/science.6815801.","journal-title":"Science"},{"key":"1688_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(20)30477-4","volume":"20","author":"P Hermann","year":"2021","unstructured":"Hermann P, Appleby B, Brandel J-P, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol. 2021;20:235\u201346. https:\/\/doi.org\/10.1016\/S1474-4422(20)30477-4.","journal-title":"Lancet Neurol"},{"key":"1688_CR4","doi-asserted-by":"publisher","first-page":"1411489","DOI":"10.3389\/fpubh.2024.1411489","volume":"12","author":"L-P Gao","year":"2024","unstructured":"Gao L-P, Tian T-T, Xiao K, Chen C, Zhou W, Liang D-L, et al. Updated global epidemiology atlas of human prion diseases. Front Public Health. 2024;12:1411489. https:\/\/doi.org\/10.3389\/fpubh.2024.1411489.","journal-title":"Front Public Health"},{"key":"1688_CR5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41582-022-00659-0","volume":"18","author":"P Hermann","year":"2022","unstructured":"Hermann P, Zerr I. Rapidly progressive dementias - aetiologies, diagnosis and management. Nat Rev Neurol. 2022;18:363\u201376. https:\/\/doi.org\/10.1038\/s41582-022-00659-0.","journal-title":"Nat Rev Neurol"},{"key":"1688_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther. 2018;10:3. https:\/\/doi.org\/10.1186\/s13195-017-0331-1.","journal-title":"Alzheimers Res Ther"},{"key":"1688_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awab350","volume":"145","author":"M Schmitz","year":"2022","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Hermann P, Escaram\u00eds G, Calero M, Chen C, et al. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain J Neurol. 2022;145:700\u201312. https:\/\/doi.org\/10.1093\/brain\/awab350.","journal-title":"Brain J Neurol"},{"key":"1688_CR8","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.1038\/s41380-021-01045-w","volume":"26","author":"AGB Thompson","year":"2021","unstructured":"Thompson AGB, Anastasiadis P, Druyeh R, Whitworth I, Nayak A, Nihat A, et al. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Mol Psychiatry. 2021;26:5955\u201366. https:\/\/doi.org\/10.1038\/s41380-021-01045-w.","journal-title":"Mol Psychiatry"},{"key":"1688_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13195-021-00815-6","volume":"13","author":"I Zerr","year":"2021","unstructured":"Zerr I, Villar-Piqu\u00e9 A, Hermann P, Schmitz M, Varges D, Ferrer I, et al. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease. Alzheimers Res Ther. 2021;13:86. https:\/\/doi.org\/10.1186\/s13195-021-00815-6.","journal-title":"Alzheimers Res Ther"},{"key":"1688_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/jnnp-2020-323826","volume":"91","author":"S Abu-Rumeileh","year":"2020","unstructured":"Abu-Rumeileh S, Baiardi S, Ladogana A, Zenesini C, Bartoletti-Stella A, Poleggi A, et al. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease. J Neurol Neurosurg Psychiatry. 2020;91:1181\u20138. https:\/\/doi.org\/10.1136\/jnnp-2020-323826.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1688_CR11","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/nprot.2016.120","volume":"11","author":"M Schmitz","year":"2016","unstructured":"Schmitz M, Cramm M, Llorens F, M\u00fcller-Cramm D, Collins S, Atarashi R, et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc. 2016;11:2233\u201342. https:\/\/doi.org\/10.1038\/nprot.2016.120.","journal-title":"Nat Protoc"},{"key":"1688_CR12","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.1038\/s41598-024-56789-6","volume":"14","author":"S Baranov\u00e1","year":"2024","unstructured":"Baranov\u00e1 S, Mo\u0161ko T, Br\u016f\u017eov\u00e1 M, Haldiman T, Kim C, Safar JG, et al. Detection of prions in matching post-mortem skin and cerebrospinal fluid samples using second-generation real-time quaking-induced conversion assay. Sci Rep. 2024;14:6294. https:\/\/doi.org\/10.1038\/s41598-024-56789-6.","journal-title":"Sci Rep"},{"key":"1688_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","volume":"74","author":"M Bongianni","year":"2017","unstructured":"Bongianni M, Orr\u00f9 C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017;74:155\u201362. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4614.","journal-title":"JAMA Neurol"},{"key":"1688_CR14","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1007\/s00415-019-09537-0","volume":"266","author":"S Abu-Rumeileh","year":"2019","unstructured":"Abu-Rumeileh S, Baiardi S, Polischi B, Mammana A, Franceschini A, Green A, et al. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC. J Neurol. 2019;266:3136\u201343. https:\/\/doi.org\/10.1007\/s00415-019-09537-0.","journal-title":"J Neurol"},{"key":"1688_CR15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/biom13060980","volume":"13","author":"LC Zanotti","year":"2023","unstructured":"Zanotti LC, Malizia F, Cesatti Laluce N, Avila A, Mamberto M, Anselmino LE, et al. Synuclein proteins in cancer development and progression. Biomolecules. 2023;13:980. https:\/\/doi.org\/10.3390\/biom13060980.","journal-title":"Biomolecules"},{"key":"1688_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/biom12010142","volume":"12","author":"J Hayashi","year":"2022","unstructured":"Hayashi J, Carver JA. \u03b2-Synuclein: an enigmatic protein with diverse functionality. Biomolecules. 2022;12:142. https:\/\/doi.org\/10.3390\/biom12010142.","journal-title":"Biomolecules"},{"key":"1688_CR17","doi-asserted-by":"publisher","first-page":"117727192095031","DOI":"10.1177\/1177271920950319","volume":"15","author":"E Camporesi","year":"2020","unstructured":"Camporesi E, Nilsson J, Brinkmalm A, Becker B, Ashton NJ, Blennow K, et al. Fluid biomarkers for synaptic dysfunction and loss. Biomark Insights. 2020;15:1177271920950319. https:\/\/doi.org\/10.1177\/1177271920950319.","journal-title":"Biomark Insights"},{"key":"1688_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1074\/mcp.RA118.001290","volume":"18","author":"A Lle\u00f3","year":"2019","unstructured":"Lle\u00f3 A, N\u00fa\u00f1ez-Llaves R, Alcolea D, Chiva C, Balateu-Pa\u00f1os D, Colom-Cadena M, et al. Changes in synaptic proteins precede neurodegeneration markers in preclinical alzheimer\u2019s disease cerebrospinal fluid. Mol Cell Proteomics MCP. 2019;18:546\u201360. https:\/\/doi.org\/10.1074\/mcp.RA118.001290.","journal-title":"Mol Cell Proteomics MCP"},{"key":"1688_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/mds.28941","volume":"37","author":"L Barba","year":"2022","unstructured":"Barba L, Paolini Paoletti F, Bellomo G, Gaetani L, Halbgebauer S, Oeckl P, et al. Alpha and beta synucleins: from pathophysiology to clinical application as biomarkers. Mov Disord Off J Mov Disord Soc. 2022;37:669\u201383. https:\/\/doi.org\/10.1002\/mds.28941.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"1688_CR20","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/acn3.51873","volume":"10","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Halbgebauer S, Bentivenga GM, Barba L, Baiardi S, Mastrangelo A, et al. High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease. Ann Clin Transl Neurol. 2023;10:1904\u20139. https:\/\/doi.org\/10.1002\/acn3.51873.","journal-title":"Ann Clin Transl Neurol"},{"key":"1688_CR21","doi-asserted-by":"publisher","unstructured":"Halbgebauer S, Abu-Rumeileh S, Oeckl P, Steinacker P, Roselli F, Wiesner D, et al. Blood \u03b2-synuclein and neurofilament light chain during the course of prion disease. Neurology 2022;98. https:\/\/doi.org\/10.1212\/WNL.0000000000200002.","DOI":"10.1212\/WNL.0000000000200002"},{"key":"1688_CR22","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1074\/mcp.M116.059915","volume":"15","author":"P Oeckl","year":"2016","unstructured":"Oeckl P, Metzger F, Nagl M, von Arnim CAF, Halbgebauer S, Steinacker P, et al. Alpha-, beta-, and gamma-synuclein quantification in cerebrospinal fluid by multiple reaction monitoring reveals increased concentrations in Alzheimer\u2019s and creutzfeldt-jakob disease but no alteration in synucleinopathies. Mol Cell Proteomics MCP. 2016;15:3126\u201338. https:\/\/doi.org\/10.1074\/mcp.M116.059915.","journal-title":"Mol Cell Proteomics MCP"},{"key":"1688_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1021\/acs.jproteome.9b00824","volume":"19","author":"P Oeckl","year":"2020","unstructured":"Oeckl P, Halbgebauer S, Anderl-Straub S, von Arnim CAF, Diehl-Schmid J, Froelich L, et al. Targeted mass spectrometry suggests beta-synuclein as synaptic blood marker in Alzheimer\u2019s disease. J Proteome Res. 2020;19:1310\u20138. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00824.","journal-title":"J Proteome Res"},{"key":"1688_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/jnnp-2020-324306","volume":"92","author":"S Halbgebauer","year":"2021","unstructured":"Halbgebauer S, Oeckl P, Steinacker P, Yilmazer-Hanke D, Anderl-Straub S, Von Arnim C, et al. Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 2021;92:349\u201356. https:\/\/doi.org\/10.1136\/jnnp-2020-324306.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1688_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.meegid.2012.11.019","volume":"14","author":"C Chen","year":"2013","unstructured":"Chen C, Shi Q, Zhou W, Zhang XC, Dong JH, Hu XQ, et al. Clinical and familial characteristics of eight Chinese patients with T188K genetic Creutzfeldt-Jakob disease. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis. 2013;14:120\u20134. https:\/\/doi.org\/10.1016\/j.meegid.2012.11.019.","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"1688_CR26","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/s41598-019-38520-y","volume":"9","author":"L-P Gao","year":"2019","unstructured":"Gao L-P, Shi Q, Xiao K, Wang J, Zhou W, Chen C, et al. The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. Sci Rep. 2019;9:1836. https:\/\/doi.org\/10.1038\/s41598-019-38520-y.","journal-title":"Sci Rep"},{"key":"1688_CR27","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s12264-021-00764-y","volume":"37","author":"Q Shi","year":"2021","unstructured":"Shi Q, Chen C, Xiao K, Zhou W, Gao LP, Chen DD, et al. Genetic prion disease: insight from the features and experience of China National Surveillance for Creutzfeldt-Jakob Disease. Neurosci Bull. 2021;37:1570\u201382. https:\/\/doi.org\/10.1007\/s12264-021-00764-y.","journal-title":"Neurosci Bull"},{"key":"1688_CR28","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fnins.2019.00934","volume":"13","author":"C Chen","year":"2019","unstructured":"Chen C, Hu C, Shi Q, Zhou W, Xiao K, Wang Y, et al. Profiles of 14\u20133-3 and total tau in CSF samples of Chinese patients of different genetic prion diseases. Front Neurosci. 2019;13:934. https:\/\/doi.org\/10.3389\/fnins.2019.00934.","journal-title":"Front Neurosci"},{"key":"1688_CR29","doi-asserted-by":"publisher","first-page":"1341886","DOI":"10.3389\/fnmol.2024.1341886","volume":"17","author":"X-X Jia","year":"2024","unstructured":"Jia X-X, Hu C, Chen C, Gao L-P, Liang D-L, Zhou W, et al. Different reactive profiles of calmodulin in the CSF samples of Chinese patients of four types of genetic prion diseases. Front Mol Neurosci. 2024;17:1341886. https:\/\/doi.org\/10.3389\/fnmol.2024.1341886.","journal-title":"Front Mol Neurosci"},{"key":"1688_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/19336896.2019.1617027","volume":"13","author":"R He","year":"2019","unstructured":"He R, Hu Y, Yao L, Tian Y, Zhou Y, Yi F, et al. Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia. Prion. 2019;13:116\u201323. https:\/\/doi.org\/10.1080\/19336896.2019.1617027.","journal-title":"Prion"},{"key":"1688_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/neup.12355","volume":"37","author":"Y Iwasaki","year":"2017","unstructured":"Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathol Off J Jpn Soc Neuropathol. 2017;37:174\u201388. https:\/\/doi.org\/10.1111\/neup.12355.","journal-title":"Neuropathol Off J Jpn Soc Neuropathol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01688-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01688-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T15:10:10Z","timestamp":1738941010000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01688-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1688"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01688-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of the National Institute for Viral Disease Control and Prevention, China CDC, under protocol 2009ZX10004-101. All participants provided informed consent by the Declaration of Helsinki and local clinical research regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}